Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commerical property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel, “In Vitro and Animal Models for Emerging Infectious Diseases and BioDefense.” (Parts C, D & E).
Date: June 8-10, 2004.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate contract proposals.
Place: Marriott Crystal City, 1999, Jefferson Davis Highway, Arlington, VA 22202.
Contact Person: Cheryl K. Lapham, PhD, Scientific Review Administrator, Scientific Review Program, National Institute of Allergy and Infectious Diseases, DEA/NIH/DHHS, 6700-B Rockledge Drive MSC 7616, Room 3127, Bethesda, MD 20892-7616. 301-402-4598; email@example.com.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS).Start Signature
Dated: May 10, 2004.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 04-11064 Filed 5-14-04; 8:45 am]
BILLING CODE 4140-01-M